Literature DB >> 29862439

Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature.

Hamza Arif1, Moeezullah Beg2, Sohaib Zahid2, Moaz Sial3, Aditya Talwar4, Antonios Christou5, Michael Babich3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 29862439     DOI： 10.1007/s12029-018-0124-1

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  14 in total

Review 1.  Clinical practice. Hypercalcemia associated with cancer.

Authors:  Andrew F Stewart
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

2.  Esophageal carcinoma with high serum parathyroid hormone-related protein (PTHrP) level.

Authors:  H A Watanabe; H Matsushita; H Matsui; T Komatsu; S Taguchi; H Sata; N Amano
Journal:  J Gastroenterol       Date:  1999-08       Impact factor: 7.527

Review 3.  Clinical review: Rare causes of hypercalcemia.

Authors:  Thomas P Jacobs; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2005-08-30       Impact factor: 5.958

4.  Oesophageal carcinoma presenting as isolated malignant hypercalcaemia.

Authors:  J M Fernández-Real; C Villabona; J Soler
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

5.  Hypercalcemia in patients with esophageal cancer.

Authors:  L G Geddes; R A Dorn; R G Wadleigh
Journal:  J Exp Clin Cancer Res       Date:  1999-03

6.  PTHrP-mediated hypercalcemia: causes and survival in 138 patients.

Authors:  Peter J Donovan; Naomi Achong; Katherine Griffin; John Galligan; Carel J Pretorius; Donald S A McLeod
Journal:  J Clin Endocrinol Metab       Date:  2015-02-26       Impact factor: 5.958

7.  Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.

Authors:  A C Hutchesson; N J Bundred; W A Ratcliffe
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

8.  Hypercalcemia in patients with esophageal carcinoma. The pathophysiologic role of parathyroid hormone-related protein.

Authors:  Y Tachimori; H Watanabe; H Kato; H Yamaguchi; K Nagasaki; S Honda; M Itabashi; K Yamaguchi
Journal:  Cancer       Date:  1991-12-15       Impact factor: 6.860

9.  Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.

Authors:  H Gurney; V Grill; T J Martin
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

Review 10.  Tumor hypercalcemia and "ectopic hyperparathyroidism".

Authors:  P Skrabanek; J McPartlin; D Powell
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.